New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Top of the News-dtet
Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Biden Launches Genomic Data Commons to Aid Sharing in Oncology
From - Diagnostic Testing & Emerging Technologies
Genomic Data Commons (GDC) launched this week as a core component of the National Cancer Moonshot and the President's Precision Medicine Initiative to promote data sharing between cancer researchers and accelerate the pace of…
Can Colorectal Screening Incorporate Adherence into Guidelines?
...
Already a member? Log in here
Is HCV Birth Cohort Testing Broad Enough?
...
Already a member? Log in here
Astronauts to Test Viability of Sequencing in Space
From - Diagnostic Testing & Emerging Technologies
Astronauts will soon conduct DNA sequencing in space. National Aeronautics and Space Administration's (NASA's) Biomolecule Sequencer investigation will…
Luminex Acquires Nanosphere with Eye Towards Growth in Molecular Microbiology
From - Diagnostic Testing & Emerging Technologies
Luminex (Austin, Texas) announced this week it will acquire molecular microbiology firm Nanosphere (Northbrook, Ill.) in a cash deal valued at…
Exome Sequencing May Enable Prenatal Diagnosis, Management
...
Already a member? Log in here
Utility of Post Op Lab Testing Questioned for Some Gynecologic Patients
...
Already a member? Log in here
At-Home Testing Company Cor Crowdfunding for Commercialization
From - Diagnostic Testing & Emerging Technologies
At-home testing company Cor (San Francisco) has taken to online crowdfunding to commercialize its blood chemistry device. As of April 6, the company had pledges on…
TAPUR Study Launches to Evaluate Off-Label Uses of Targeted Cancer Therapies
From - Diagnostic Testing & Emerging Technologies
The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by …
ACMG Studies Provide Lessons in Genetic Test Ordering Management
...
Already a member? Log in here